TY - JOUR
T1 - Auricular Point Acupressure Combined with Compound Lidocaine Cream to Manage Arteriovenous Fistula Puncture Pain
T2 - A Multicenter Randomized Controlled Trial
AU - Liu, Xiaohui
AU - Wei, Wei
AU - Wu, Yaqi
AU - Jiang, Xiao
AU - Liu, Xueqin
AU - Zhang, Ying
AU - Yeh, Chao Hsing
AU - Zhang, Yuejuan
N1 - Publisher Copyright:
© 2021 Xiaohui Liu et al.
PY - 2021
Y1 - 2021
N2 - Background. Arteriovenous fistula (AVF) puncture pain is an inevitable problem for maintenance hemodialysis (MHD) patients and may seriously endanger the physical and mental health of patients with MHD. Studies have shown that drug or nondrug measures can reduce AVF puncture pain, but much improvement is needed. When combined with compound lidocaine cream (CLC) in the treatment of AVF puncture pain, auricular point acupressure (APA) - a therapeutic method in which specific points on the auricle of the outer ear are stimulated to treat various disorders of the body - and the therapeutic value and synergistic effects of auriculotherapy merit further investigation. Methods. 120 MHD patients were recruited at blood purification centers in three hospitals between January 2016 and April 2019. After completion of the baseline survey, all patients were randomly divided by the envelope method into a control group, APA group, CLC group, and APA combined with CLC, with 30 subjects per group. The numerical rating scale (NRS) of pain was used to measure the pain before intervention and 1, 4, and 8 weeks after intervention. The State-Trait Anxiety Inventory (STAI), General Comfort Questionnaire (GCQ), blood pressure, and heart rates were obtained before and after the intervention. Results. Pain, anxiety, comfort, blood pressure (BP), and heart rates (HR) of the three groups were better than those of the control group; the difference was statistically significant (P<0.05). In addition, the APA combined with CLC group was better than the APA group and CLC group, respectively, in those outcomes (P<0.05). Conclusion. Both APA and CLC can effectively relieve AVF puncture pain, and the combined application has more outstanding effects.
AB - Background. Arteriovenous fistula (AVF) puncture pain is an inevitable problem for maintenance hemodialysis (MHD) patients and may seriously endanger the physical and mental health of patients with MHD. Studies have shown that drug or nondrug measures can reduce AVF puncture pain, but much improvement is needed. When combined with compound lidocaine cream (CLC) in the treatment of AVF puncture pain, auricular point acupressure (APA) - a therapeutic method in which specific points on the auricle of the outer ear are stimulated to treat various disorders of the body - and the therapeutic value and synergistic effects of auriculotherapy merit further investigation. Methods. 120 MHD patients were recruited at blood purification centers in three hospitals between January 2016 and April 2019. After completion of the baseline survey, all patients were randomly divided by the envelope method into a control group, APA group, CLC group, and APA combined with CLC, with 30 subjects per group. The numerical rating scale (NRS) of pain was used to measure the pain before intervention and 1, 4, and 8 weeks after intervention. The State-Trait Anxiety Inventory (STAI), General Comfort Questionnaire (GCQ), blood pressure, and heart rates were obtained before and after the intervention. Results. Pain, anxiety, comfort, blood pressure (BP), and heart rates (HR) of the three groups were better than those of the control group; the difference was statistically significant (P<0.05). In addition, the APA combined with CLC group was better than the APA group and CLC group, respectively, in those outcomes (P<0.05). Conclusion. Both APA and CLC can effectively relieve AVF puncture pain, and the combined application has more outstanding effects.
UR - http://www.scopus.com/inward/record.url?scp=85112400635&partnerID=8YFLogxK
U2 - 10.1155/2021/5573567
DO - 10.1155/2021/5573567
M3 - 文章
AN - SCOPUS:85112400635
SN - 1741-427X
VL - 2021
JO - Evidence-based Complementary and Alternative Medicine
JF - Evidence-based Complementary and Alternative Medicine
M1 - 5573567
ER -
